| Literature DB >> 27453483 |
Tamas Dolowschiak1, Anna Angelika Mueller2, Lynn Joanna Pisan2, Rounak Feigelman3, Boas Felmy2, Mikael Erik Sellin2, Sukumar Namineni4, Bidong Dinh Nguyen2, Sandra Yvonne Wotzka2, Mathias Heikenwalder5, Christian von Mering3, Christoph Mueller6, Wolf-Dietrich Hardt7.
Abstract
Salmonella Typhimurium (S.Tm) causes acute enteropathy resolving after 4-7 days. Strikingly, antibiotic therapy does not accelerate disease resolution. We screened for factors blocking remission using a S.Tm enterocolitis model. The antibiotic ciprofloxacin clears pathogen stool loads within 3-24 hr, while gut pathology resolves more slowly (ψ50: ∼48 hr, remission: 6-9 days). This delayed resolution is mediated by an interferon-γ (IFN-γ)-dependent response that is triggered during acute infection and continues throughout therapy. Specifically, IFN-γ production by mucosal T and NK cells retards disease resolution by maintaining signaling through the transcriptional regulator STAT1 and boosting expression of inflammatory mediators like IL-1β, TNF, and iNOS. Additionally, sustained IFN-γ fosters phagocyte accumulation and hampers antimicrobial defense mediated by IL-22 and the lectin REGIIIβ. These findings reveal a role for IFN-γ in delaying resolution of intestinal inflammation and may inform therapies for acute Salmonella enteropathy, chronic inflammatory bowel diseases, or disease resolution during antibiotic treatment.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27453483 DOI: 10.1016/j.chom.2016.06.008
Source DB: PubMed Journal: Cell Host Microbe ISSN: 1931-3128 Impact factor: 21.023